CMS has announced a final rule ending federal CHIP and Medicaid funds for gender-affirming care in youth.The policy is scheduled to take effect on Oct. 13, but the funding “will be available for a tapering-off period of up to 6 months from the effective date of the final rule for children currently on hormone therapy,” according to a press release from CMS.

HHS finalized a rule prohibiting Medicaid payments for child gender medicine, including puberty blockers, cross-sex hormones, and surgeries.

The Trump administration has finalized a rule that would pull funding for gender-affirming care for minors from Medicaid and the Children's Health Insurance Program. | The Trump…